It is our great pleasure to announce the 4th congress of the Swiss Federation of Clinical Neuro-Societies (SFCNS), which will take place in Lausanne at the SwissTech Convention Center from October 23 to 25, 2019.
Starting with the the 6 original (founding) societies (Neurology, Neurosurgery, Neuroradiology, Neuropediatrics, Neuropathology and Clinical Neurophysiology), the federation has over the last years grown to encompass most if not all societies and individuals involved in managing diseases of the central nervous system in Switzerland.
Ever since its foundation, the SFCNS has undertaken efforts to improve the quality and visibility of Swiss neuroscience – locally, nationally and internationally. This has been done with great success by promoting clinical excellence, scientific research as well as political lobbying. Further, collaboration and exchange between the various clinical neurosocieties which form the SFCNS have been promoted.
The SFCNS has thus successfully been active in the creation and certification of world-class stroke centers as well as in defining the criteria by which Highly Specialized Medicine (HSM) is to be practiced in Switzerland in the domain of clinical neurosciences. Since its founding in 2009 and the first congress in 2010, the SFCNS has continuously grown and expanded its success, vision and influence. In addition to the congress, the Society has successfully developed summer schools to attract its members and further established the Journal Clinical and Translational Neuroscience as its own vehicle for scientific publications.
One of the central factors for the success of the SFCNS is its triennial congress, which represents a unique encounter between not just the various societies which form its core but also of adjacent specialities that will contribute to our common future. Thus, it is exceedingly important that the congress does not only represent the various member societies, but that it also has a spirit of its own.
The fourth congress of the SFCNS is this time not just held in any congress center, but in the heart of Swiss technological innovation at the SwissTech Convention Center, which is located in the heart of the campus of the Ecole Polytechnique Fedeale de Lausanne (EPFL). This represents a breakout from the previous locations Basel and Montreux and is of extreme importance to us all, since clinical neuroscience has benefited from advances in technology since its inception. Further, leaders in neuroscience very often contribute to technological developments themselves. Therefore, additionally to the traditional neuro-science participants we will see participants from fields of technologies such as basic neuroimaging, robotics and artificial intelligence that have contributed and will further contribute to the definition of the way clinical neuroscientists work over the next century.
The congress program is extremely rich and varied and proposes a multitude of formats for presenting knowledge and advances in neuroscientific areas: the days will start with plenary sessions that will be followed by satellite symposia and parallel sessions devoted to topics of clinical and scientific interest.
We hope that you will join us in Lausanne for this exciting event and that you will have as much pleasure attending the congress as we have in organizing it.
Prof. Karl Olof Lövblad, MD Prof. Karl Schaller, MD
Congress President President SFCNS